28 November 2024

Built with 15+ years of sdAb experience, QSyLi combines the diversity of an entire VHH germline with cutting-edge nature-inspired diversification. Designed to accelerate discovery, QSyLi eliminates immunization while enabling exploration of non-immunogenic and toxic targets.

Discover how QSyLi is transforming antibody discovery with faster, animal-free workflows, designed for innovation and sustainability in biotechnology.